Cargando…

Identification and characterization of novel ETV4 splice variants in prostate cancer

ETV4, one of ETS proteins overexpressed in prostate cancer, promotes migration, invasion, and proliferation in prostate cells. This study identifies a series of previously unknown ETV4 alternatively spliced transcripts in human prostate cell lines. Their expression has been validated using several u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cosi, Irene, Moccia, Annalisa, Pescucci, Chiara, Munagala, Uday, Di Giorgio, Salvatore, Sineo, Irene, Conticello, Silvestro G., Notaro, Rosario, De Angioletti, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066307/ https://www.ncbi.nlm.nih.gov/pubmed/37002241 http://dx.doi.org/10.1038/s41598-023-29484-1

Ejemplares similares

ETV4 promotes late development of prostatic intraepithelial neoplasia and cell proliferation through direct and p53-mediated downregulation of p21
por: Cosi, Irene, et al.
Publicado: (2020)

Overexpression of ETV4 is oncogenic in prostate cells through promotion of both cell proliferation and epithelial to mesenchymal transition
por: Pellecchia, A, et al.
Publicado: (2012)

Splice Variants of Activation Induced Deaminase (AID) Do Not Affect the Efficiency of Class Switch Recombination in Murine CH12F3 Cells
por: Sala, Cesare, et al.
Publicado: (2015)

Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients
por: Martignano, Filippo, et al.
Publicado: (2021)

A fluorescent reporter for quantification and enrichment of DNA editing by APOBEC–Cas9 or cleavage by Cas9 in living cells
por: St. Martin, Amber, et al.
Publicado: (2018)

Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts
por: Mesquita, Diana, et al.
Publicado: (2015)

Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2
por: Di Giorgio, Salvatore, et al.
Publicado: (2020)

Structured and disordered regions cooperatively mediate DNA-binding autoinhibition of ETS factors ETV1, ETV4 and ETV5
por: Currie, Simon L., et al.
Publicado: (2017)

Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer
por: Attard, G, et al.
Publicado: (2008)

Eculizumab treatment: stochastic occurrence of C3 binding to individual PNH erythrocytes
por: Sica, Michela, et al.
Publicado: (2017)

Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis
por: Lu, Benson, et al.
Publicado: (2009)

Splice Variants of Androgen Receptor and Prostate Cancer
por: Caffo, Orazio, et al.
Publicado: (2016)

Splice-disrupt genomic variants in prostate cancer
por: Alanazi, Ibrahim O., et al.
Publicado: (2022)

The AID/APOBEC family of nucleic acid mutators
por: Conticello, Silvestro G
Publicado: (2008)

ERG is specifically associated with ETS-2 and ETV-4, but not with ETS-1, in prostate cancer
por: ADLER, DAVID, et al.
Publicado: (2012)

Portrait of Molecular Signaling and Putative Therapeutic Targets in Prostate Cancer with ETV4 Fusion
por: Shin, Ye Ji, et al.
Publicado: (2022)

ETV3 and ETV6 enable monocyte differentiation into dendritic cells by repressing macrophage fate commitment
por: Villar, Javiera, et al.
Publicado: (2022)

Description of an Institutional Cohort of Myeloid Neoplasms Carrying ETV6-Locus Deletions or ETV6 Rearrangements
por: Papadopoulou, Vasiliki, et al.
Publicado: (2023)

Long-term quality of life after ETV or ETV with consecutive VP shunt placement in hydrocephalic pediatric patients
por: Bogaczyk, Victoria, et al.
Publicado: (2022)

Heidelberg ETV score to assess success of ETV in patients with occlusive hydrocephalus: a retrospective single-center study
por: Issa, Mohammed, et al.
Publicado: (2023)

Overexpression of Full-Length ETV1 Transcripts in Clinical Prostate Cancer Due to Gene Translocation
por: Gasi, Delila, et al.
Publicado: (2011)

YK-4-279 Inhibits ERG and ETV1 Mediated Prostate Cancer Cell Invasion
por: Rahim, Said, et al.
Publicado: (2011)

Structures of the Ets Protein DNA-binding Domains of Transcription Factors Etv1, Etv4, Etv5, and Fev: DETERMINANTS OF DNA BINDING AND REDOX REGULATION BY DISULFIDE BOND FORMATION
por: Cooper, Christopher D. O., et al.
Publicado: (2015)

ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer
por: Li, Dan, et al.
Publicado: (2023)

Flow-cytometric visualization of C>U mRNA editing reveals the dynamics of the process in live cells
por: Severi, Francesco, et al.
Publicado: (2015)

The RNA editing enzyme APOBEC1 induces somatic mutations and a compatible mutational signature is present in esophageal adenocarcinomas
por: Saraconi, Giulia, et al.
Publicado: (2014)

Erratum: The RNA editing enzyme APOBEC1 induces somatic mutations and a compatible mutational signature is present in esophageal adenocarcinomas
por: Saraconi, Giulia, et al.
Publicado: (2014)

A Case of Chronic Myeloid Leukemia With Rare Variant ETV6/ABL1 Rearrangement
por: Choi, Soo In, et al.
Publicado: (2017)

Identification of Androgen Receptor Splice Variants in the Pten Deficient Murine Prostate Cancer Model
por: Liang, Mengmeng, et al.
Publicado: (2015)

Role of androgen receptor splice variants in prostate cancer metastasis
por: Xu, Jin, et al.
Publicado: (2016)

Correction to: Long‑term quality of life after ETV or ETV with consecutive VP shunt placement in hydrocephalic pediatric patients
por: Bogaczyk, Victoria, et al.
Publicado: (2022)

Connections Between ETV6-Modulated Genes: Identification of Shared Features
por: Boily, Gino, et al.
Publicado: (2008)

miR-129-5p inhibits prostate cancer proliferation via targeting ETV1
por: Gao, Ge, et al.
Publicado: (2019)

ETV2 mediates endothelial transdifferentiation of glioblastoma
por: Zhao, Chengjian, et al.
Publicado: (2018)

ETV4: an emerging target in pancreatic cancer
por: Deshmukh, Sachin Kumar, et al.
Publicado: (2018)

Hereditary platelet disorders associated with germ line variants in RUNX1, ETV6, and ANKRD26
por: Homan, Claire C., et al.
Publicado: (2023)

Correction: Identification of Androgen Receptor Splice Variants in the Pten Deficient Murine Prostate Cancer Model
por: Liang, Mengmeng, et al.
Publicado: (2016)

Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer
por: Rastogi, Anshu, et al.
Publicado: (2014)

Androgen receptor splice variants and prostate cancer: From bench to bedside
por: Wadosky, Kristine M., et al.
Publicado: (2017)

The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness
por: Hormaechea-Agulla, Daniel, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_k8hs1b28ddrpdcm64sd7kso572